Brian T. Powl, Chief Commercial Officer at Kura Oncology, Inc. (KURA), sold 339 shares at $9.21 ($3K) on 2026-05-19, disclosed to the SEC on 2026-05-20.
Scheduled sale ($3k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KURA | SELL | 2026-01-27 | $54K | — | Filing → |
| KURA | SELL | 2025-11-14 | $199K | — | Filing → |
| KURA | SELL | 2025-09-29 | $159K | — | Filing → |